- Home
- About
- Section Advisors
- Meet Our Field Medical Affairs Team
- Speakers Bureau
- Supporting Organizations
- Contact Us
- PsychU For You
- Topics
- Mental Health Disorders
- Agitation
- Attention Deficit Hyperactivity Disorder (ADHD)
- Bipolar Disorder
- Depression
- Pseudobulbar Affect (PBA)
- PTSD/Trauma
- Schizophrenia
- Substance Use Disorders
- Topics of Interest
- Care Coordination
- Digital Health
- Diversity, Equity, & Inclusion
- Health Care Policy, Quality & Payer Administration
- Long-Term Care
- Stigma
- Suicide Awareness
- Wellness
- Events
- Content
- Infographics
- Learning Tracks
- Podcasts
- Shareable/Downloadable Content
- Videos
- PsychUSim
- PsychU Roleplay
- Frameworks In Health & Quality Resources
- Mental Health System Guidebooks
- Psychiatric Scales
- Psychopharmacology
- Supporting Organizations
Pseudobulbar Affect (PBA) In Geriatric & Long-Term Care Patients
Thank You For Attending Today’s Webinar
Please tell us what you thought about today’s presentation by taking the survey below:
About This Event
Pseudobulbar Affect (PBA) In Geriatric & Long-Term Care Patients
PBA is a neurologic condition that occurs secondary to a variety of otherwise unrelated neurologic conditions and is characterized by sudden, frequent, uncontrollable episodes of laughing and/or crying.1,2 Residents in long-term care settings with PBA symptoms may have different characteristics with their medication usage or behavioral symptoms compared to those residents without PBA symptoms.3,4 In this webinar, our panelists will be reviewing PBA characteristics, neurocircuitry and pathophysiology, PBA prevalence, the impact of PBA on patients and assessment of PBA symptoms.
References:-
1. Cummings JL, et al. CNS Spectr. 2006;11(6):1-7
2. Wortzel HS, et al. CNS Drugs. 2008; 22(7):531-545
3. Foley K et al. Int J Geriatr Psychiatry. 2016;31:694-701
4. Zarowitz BJ, et al. Consultant Pharm. 2013;28:713-22Featuring
Justin Rash, PharmD, BCGP (OPDC)
Senior Medical Science Liaison
Michelle Lavagnino, DrPH(c)
Medical Science Liaison, Long-term Care
Justin Rash and Michelle Lavagnino are employees of Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC)
Registration
Related Resources
-
Psychometric Validation of the AASC®: Supporting Early Detection & Improving Caregiver-HCP communication in Agitation Associated With Dementia Due to Alzheimer’s Disease (AAD)
On-Demand Webinar December 3, 2025In this webinar, Dr. Carolyn Clevenger will provide both background on AASC® tool development and details on AASC® quantitative validation study design and results.
-
Myths & Misconceptions: Bipolar Disorder
Podcast November 10, 2025Please join us as Dr. Mauricio Tohen explores common myths and misconceptions about bipolar disorder, from diagnosis and treatment to public perception.
-
Understanding the Complexity of Attention-Deficit Hyperactivity Disorder
On-Demand Webinar October 16, 2025Dr. Childress will discuss how the interplay between norepinephrine, dopamine and serotonin plays a critical role in ADHD neurobiology. Lastly, Dr. Childress will summarize the unmet needs of current treatments…
Join today for instant access to all PsychU content, events, and more!
Membership is free!
"*" indicates required fields
Join PsychU Today to receive a wide array of tools and benefits
- Join our multidisciplinary community that is improving mental health care… together
- Quickly learn more about the topics you're interested in
- Access an award-winning library of on-demand mental health resources
- Gain key insights from industry expert & thought leaders
Stay Connected: